High materiality8/10
Wells Fargo upgrades Editas Medicine after EDIT-401 study gets green light
Why it may matterVerify against the original reporting
Very bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo upgrades EDIT after EDIT-401 study gets green light; current price 2.81, target 6.
- Wells Fargo upgrade; EDIT target $6; price $2.81.
Key facts
- 01
Target: $6
- 02
Posted price: $2.81
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.